Carbon footprint impact of the choice of inhalers for asthma and COPD

In the 1990s, metered dose inhalers (MDIs) containing chlorofluorocarbons were replaced with dry-powder inhalers (DPIs) and MDIs containing hydrofluorocarbons (HFCs). While HFCs are not ozone depleting, they are potent greenhouse gases. Annual carbon footprint (CO(2)e), per patient were 17 kg for Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Janson, Christer, Henderson, Richard, Löfdahl, Magnus, Hedberg, Martin, Sharma, Raj, Wilkinson, Alexander J K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929707/
https://www.ncbi.nlm.nih.gov/pubmed/31699805
http://dx.doi.org/10.1136/thoraxjnl-2019-213744
_version_ 1783482755329294336
author Janson, Christer
Henderson, Richard
Löfdahl, Magnus
Hedberg, Martin
Sharma, Raj
Wilkinson, Alexander J K
author_facet Janson, Christer
Henderson, Richard
Löfdahl, Magnus
Hedberg, Martin
Sharma, Raj
Wilkinson, Alexander J K
author_sort Janson, Christer
collection PubMed
description In the 1990s, metered dose inhalers (MDIs) containing chlorofluorocarbons were replaced with dry-powder inhalers (DPIs) and MDIs containing hydrofluorocarbons (HFCs). While HFCs are not ozone depleting, they are potent greenhouse gases. Annual carbon footprint (CO(2)e), per patient were 17 kg for Relvar-Ellipta/Ventolin-Accuhaler; and 439 kg for Seretide-Evohaler/Ventolin-Evohaler. In 2017, 70% of all inhalers sold in England were MDI, versus 13% in Sweden. Applying the Swedish DPI and MDI distribution to England would result in an annual reduction of 550 kt CO(2)e. The lower carbon footprint of DPIs should be considered alongside other factors when choosing inhalation devices.
format Online
Article
Text
id pubmed-6929707
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69297072020-01-06 Carbon footprint impact of the choice of inhalers for asthma and COPD Janson, Christer Henderson, Richard Löfdahl, Magnus Hedberg, Martin Sharma, Raj Wilkinson, Alexander J K Thorax Brief Communication In the 1990s, metered dose inhalers (MDIs) containing chlorofluorocarbons were replaced with dry-powder inhalers (DPIs) and MDIs containing hydrofluorocarbons (HFCs). While HFCs are not ozone depleting, they are potent greenhouse gases. Annual carbon footprint (CO(2)e), per patient were 17 kg for Relvar-Ellipta/Ventolin-Accuhaler; and 439 kg for Seretide-Evohaler/Ventolin-Evohaler. In 2017, 70% of all inhalers sold in England were MDI, versus 13% in Sweden. Applying the Swedish DPI and MDI distribution to England would result in an annual reduction of 550 kt CO(2)e. The lower carbon footprint of DPIs should be considered alongside other factors when choosing inhalation devices. BMJ Publishing Group 2020-01 2019-11-07 /pmc/articles/PMC6929707/ /pubmed/31699805 http://dx.doi.org/10.1136/thoraxjnl-2019-213744 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Brief Communication
Janson, Christer
Henderson, Richard
Löfdahl, Magnus
Hedberg, Martin
Sharma, Raj
Wilkinson, Alexander J K
Carbon footprint impact of the choice of inhalers for asthma and COPD
title Carbon footprint impact of the choice of inhalers for asthma and COPD
title_full Carbon footprint impact of the choice of inhalers for asthma and COPD
title_fullStr Carbon footprint impact of the choice of inhalers for asthma and COPD
title_full_unstemmed Carbon footprint impact of the choice of inhalers for asthma and COPD
title_short Carbon footprint impact of the choice of inhalers for asthma and COPD
title_sort carbon footprint impact of the choice of inhalers for asthma and copd
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929707/
https://www.ncbi.nlm.nih.gov/pubmed/31699805
http://dx.doi.org/10.1136/thoraxjnl-2019-213744
work_keys_str_mv AT jansonchrister carbonfootprintimpactofthechoiceofinhalersforasthmaandcopd
AT hendersonrichard carbonfootprintimpactofthechoiceofinhalersforasthmaandcopd
AT lofdahlmagnus carbonfootprintimpactofthechoiceofinhalersforasthmaandcopd
AT hedbergmartin carbonfootprintimpactofthechoiceofinhalersforasthmaandcopd
AT sharmaraj carbonfootprintimpactofthechoiceofinhalersforasthmaandcopd
AT wilkinsonalexanderjk carbonfootprintimpactofthechoiceofinhalersforasthmaandcopd

Ejemplares similares